Vira Health is a technology company.
Vira Health has raised $14.0M across 2 funding rounds.
Key people at Vira Health.
Vira Health has raised $14.0M in total across 2 funding rounds.
Key people at Vira Health.
Vira Health has raised $14.0M in total across 2 funding rounds.
Vira Health's investors include Archimedes Accelerator LLC, Atomico, Audrey Capital, Expon Capital, LocalGlobe, Octopus Ventures, True Ventures, Zinc, Bryan Meehan, Evelyn Bourke, Alumni Ventures, Cherry Ventures.
Vira Health is a London-based technology company founded in 2019 (with operations scaling from 2020) that builds a digital platform for personalized menopause care, integrating self-directed tools, clinical support, and AI-driven decision aids.[3][5] Its core product, the Stella app and ViraMD SaaS tool, serves women experiencing menopausal symptoms, clinicians, healthcare providers, hospitals, and health systems by delivering tailored hormone therapy recommendations, behavioral interventions like CBT, exercise programs, and ongoing monitoring to address issues such as insomnia, incontinence, low mood, and weight gain.[1][4] The platform solves the problem of limited access to specialized menopause care—reducing clinician time from 45 minutes per patient to automated triage, cutting follow-up visits from four to one annually, and shortening NHS waitlists through safer, efficient prescribing based on 200+ data points from patient questionnaires.[1][4][5] Growth momentum includes reaching over 2 million people, securing $12M in Series A funding in 2022 from Octopus Ventures and Optum Ventures, NHS case study successes, and U.S. expansion plans.[4][5]
Vira Health emerged from a conversation between co-founders Frances and Tanya Berchowitz, who identified menopause as an "untapped" opportunity to transform women's health through technology, blending personalized digital therapeutics with clinical best practices.[4] Launched in the U.K. in 2020 (building on 2019 founding), the Stella app debuted in August 2021, initially focusing on symptom-specific 12-week programs like CBT for sleep or pelvic floor exercises for incontinence.[4][5] Early traction came via partnerships with public systems like the UK's National Health Service, where ViraMD enabled task-shifting from MDs to lower-level clinicians, improved safety in first prescriptions, and integrated behavioral care without waitlists—pivotal for scaling to over 2 million users and global healthcare collaborations.[1][5]
Vira Health rides the wave of women's health tech and digital therapeutics, targeting the underserved menopause market—affecting millions amid aging populations and rising demand for non-invasive, scalable care amid clinician shortages.[3][4] Timing aligns with post-pandemic telehealth acceleration and investor interest in femtech (e.g., $12M raise amid U.S. expansion), fueled by market forces like NHS backlogs and global health system strains favoring AI triage over specialist visits.[1][4] It influences the ecosystem by partnering with public/private providers, normalizing menopause as a tech-addressable "longevity" phase (expanding to bone/brain/heart health), and advancing RAG-based AI for evidence-driven chatbots, bridging consumer apps with regulated clinical tools.[5][6]
Vira Health is poised to dominate menopause care through SaaS expansion into U.S. health systems and beyond, leveraging AI for predictive refinements in hormone therapy and holistic aging support.[1][4][5] Trends like AI integration in femtech, regulatory nods for digital therapeutics, and employer wellness demands will propel growth, potentially evolving its influence from U.K. pioneer to global platform powering personalized women's longevity.[3][5] As it scales from 2 million reached, expect deeper EHR embeds and multi-condition extensions, redefining accessible, data-driven care for midlife women.
Vira Health has raised $14.0M across 2 funding rounds. Most recently, it raised $12.0M Series A in March 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2022 | $12.0M Series A | Archimedes Accelerator LLC, Atomico, Audrey Capital, Expon Capital, LocalGlobe, Octopus Ventures, True Ventures, Zinc, Bryan Meehan, Evelyn Bourke | |
| Jul 1, 2021 | $2.0M Seed | Alumni Ventures, Cherry Ventures, foobar.vc, LocalGlobe, MMC Ventures, Octopus Ventures, Radicle Ventures, Speedinvest, True Ventures, Union Square Ventures, Martin Enderle, Moaffak Ahmed |
